Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS

NCT01882946 is registered in ClinicalTrials.gov with Northwest Biotherapeutics as lead sponsor.

NCT NCT01882946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01882946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS
Lead sponsor
Northwest Biotherapeutics
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2013
Completion date
Not reported
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, liver cancer, locally advanced tumor, melanoma, metastatic solid tissue tumors, pancreatic cancer